Citation: Fm. Gribble et al., Randomised dose ranging study of the reduction of fasting and postprandialglucose in type 2 diabetes by nateglinide (A-4166), DIABET CARE, 24(7), 2001, pp. 1221-1225
Citation: Fm. Ashcroft et Fm. Gribble, Tissue-specific effects of sulfonylureas lessons from studies of cloned K-ATP channels, J DIABET C, 14(4), 2000, pp. 192-196
Citation: F. Reimann et al., Differential response of K-ATP channels containing SUR2A or SUR2B subunitsto nucleotides and pinacidil, MOLEC PHARM, 58(6), 2000, pp. 1318-1325
Authors:
Gribble, FM
Reimann, F
Ashfield, R
Ashcroft, FM
Citation: Fm. Gribble et al., Nucleotide modulation of pinacidil stimulation of the cloned K-ATP channelKir6.2/SUR2A, MOLEC PHARM, 57(6), 2000, pp. 1256-1261
Citation: Fm. Gribble et Fm. Ashcroft, Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues, METABOLISM, 49(10), 2000, pp. 3-6
Citation: Fm. Ashcroft et Fm. Gribble, ATP-sensitive K+ channels and insulin secretion: their role in health and disease, DIABETOLOG, 42(8), 1999, pp. 903-919
Citation: Fm. Gribble et Fm. Ashcroft, Differential sensitivity of beta-cell and extrapancreatic K-ATP channels to gliclazide, DIABETOLOG, 42(7), 1999, pp. 845-848
Authors:
Ashfield, R
Gribble, FM
Ashcroft, SJH
Ashcroft, FM
Citation: R. Ashfield et al., Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K-ATP channel, DIABETES, 48(6), 1999, pp. 1341-1347
Authors:
Le Brigand, L
Virsolvy, A
Manechez, D
Godfroid, JJ
Guardiola-Lemaitre, B
Gribble, FM
Ashcroft, FM
Bataille, D
Citation: L. Le Brigand et al., In vitro mechanism of action on insulin release of S-22068, a new putativeantidiabetic compound, BR J PHARM, 128(5), 1999, pp. 1021-1026